Advertisement
Screener

Vaccinex, Inc. (VCNX) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

Vaccinex, Inc. Retained Earnings

Vaccinex, Inc. (VCNX) had Retained Earnings of -$358.56 million as of 2024-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-04-15

  • 2024-12-31: Retained Earnings (Accumulated Deficit) -$358.56M.
  • 2024-09-30: Retained Earnings (Accumulated Deficit) -$355.19M.
  • 2024-06-30: Retained Earnings (Accumulated Deficit) -$349.45M.
  • 2024-03-31: Retained Earnings (Accumulated Deficit) -$343.82M.
Period endRetained Earnings (Accumulated Deficit)
2024-12-31-$358.56M
10-K · filed 2025-04-15
2024-09-30-$355.19M
10-Q · filed 2024-11-14
2024-06-30-$349.45M
10-Q · filed 2024-08-14
2024-03-31-$343.82M
10-Q · filed 2024-05-15
2023-12-31-$339.93M
10-K · filed 2025-04-15
2023-09-30-$336.61M
10-Q · filed 2023-11-13
2023-06-30-$331.70M
10-Q · filed 2023-08-14
2023-03-31-$324.64M
10-Q · filed 2023-05-15
2022-12-31-$319.68M
10-K/A · filed 2024-04-25
2022-09-30-$314.60M
10-Q · filed 2022-11-14
2022-06-30-$309.84M
10-Q · filed 2022-08-15
2022-03-31-$304.46M
10-Q · filed 2022-05-16
2021-12-31-$299.86M
10-K · filed 2023-03-31
2021-09-30-$295.23M
10-Q · filed 2021-11-08
2021-06-30-$290.02M
10-Q · filed 2021-08-16
2021-03-31-$284.06M
10-Q · filed 2021-05-17
2020-12-31-$277.48M
10-K · filed 2022-03-31
2020-09-30-$271.03M
10-Q · filed 2020-11-13
2020-06-30-$262.28M
10-Q · filed 2020-08-14
2020-03-31-$255.78M
10-Q · filed 2020-05-14
2019-12-31-$248.63M
10-K · filed 2021-03-31
2019-09-30-$242.30M
10-Q · filed 2019-11-12
2019-06-30-$234.66M
10-Q · filed 2019-08-14
2019-03-31-$225.83M
10-Q · filed 2019-05-15
2018-12-31-$216.77M
10-K · filed 2020-03-09
2018-09-30-$208.32M
10-Q · filed 2018-11-13
2018-06-30-$201.72M
10-Q · filed 2018-08-14
2017-12-31-$187.25M
10-K · filed 2019-03-13